Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

E-ISSN： 1365-2036|47|5|588-595

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.5, 2018-03, pp. : 588-595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long‐term outcomes of thalidomide in refractory Crohn's disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 429-437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 5, 2015-05 ,pp. : 1371-1383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Ivabradine in Patients with Chronic Stable Angina

Cardiology, Vol. 108, Iss. 4, 2007-09 ,pp. : 387-396

Karger

Access to resources Recommend Favorite

Fecal microbiota transplantation

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 51-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension

By Littlejohn Thomas W. Trenkwalder Peter Hollanders Geert Zhao Yanxing Liao Weichi

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 951-959

Informa Healthcare

Access to resources Recommend Favorite